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Objectives: Diabetes mellitus, depression, and excessive
daytime sleepiness (EDS) are common health disorders
that are associated with significant mortality and
morbidity. When observed together, these disorders pre-
cipitate the other’s deleterious effects. In this study, we
aimed to study depression, anxiety, EDS, and their rela-
tion with diabetes control among patients with type 2
diabetes mellitus in Tabuk, KSA.
Methods: This case-control study was conducted in a
diabetes centre in Tabuk during March to June 2015. One
hundred and seventy-eight diabetic and one hundred
control patients signed a written informed consent. These
participants were then interviewed using the Arabic ver-
sions of Beck Depression Inventory (BDI), Epworth
Sleepiness Scale (ESS), and Hamilton Anxiety Scale
(HAS). The Statistical Package for Social Sciences (SPSS)
was used for data analysis.
Results: Depression was evident in 61.8% of diabetic
patients vs. 30% in controls. EDS was found in 6.7% of
diabetic patients and was not reported in controls (P-
value < 0.05), whereas anxiety was reported in 4.3% of
patients and controls with no statistically significant dif-
ference. No differences were evident between patients
with depression, EDS, and anxiety and those without
these disorders in terms of diabetes control and body
mass index.
Conclusion: In this study, depression and EDS were
common among diabetic patients, although there was no
difference with the prevalence of anxiety between diabetic
and control patients. In addition, no differences werey. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2016.05.009
H.O. Mirghani and A.S. Elbadawi 375found between patients with poor diabetes control and
those who attempted to control their depression, EDS,
and anxiety.
Keywords: Anxiety; Depression; KSA; Sleepiness; Type 2
diabetes
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University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
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The global prevalence of diabetes is expected to rise from
the current number of 285 million people to 438 million by
the year 2030, with Asian countries suffering the bulk of the
total diabetes epidemic. The KSA is among the countries
with the highest prevalence of diabetes mellitus (17.6%).1,2
Major depression is a common chronic recurrent disease;
it is associated with morbidity, mortality, and reduced
quality of life. According to World Health Organization,
major depression is ranked the 4th leading cause of disability
worldwide and is projected to be the second leading cause by
the year 2020.3 There is wide variation in the prevalence
across countries with the highest rates being reported in
high-income countries. Additionally, the disease is more
common among women. The twelve-month prevalence var-
ied from 9.3% to 23% in subjects with chronic morbid dis-
eases and 3.2% in those without co-morbid diseases.4
Depression is a common co-morbidity with diabetes
mellitus in particular as well as other chronic medical ill-
nesses. Depression in diabetic patients occurs as a direct
consequence of neurochemical changes with diabetes, and
the complex interaction between genetic and bio-psycho-
social factors.5 The prevalence of depression in patients
with diabetes mellitus was found to be 11% in a meta-
analysis of 42 published studies that included 21,351 adults.6
A study conducted in Eastern KSA among patients with
diabetes mellitus concluded that nearly half of patients
(49.6%) were depressed.7
Although depression and anxiety are common worldwide,
the majority are in developing countries and are associated
with high morbidity and mortality in patients with diabetes
mellitus.8 The presence of depression in patients with
diabetes substantially reduces patient self-care and func-
tional abilities with harmful effects on patient health.9
In comparison to diabetic patients without depression,
depressed diabetic patients are less likely to adhere to self-
management and medication use resulting in poor glycae-
mic control and higher complications aggravating their
depression.10
Despite its association with frequent co-morbidity in pa-
tients with diabetes mellitus, anxiety is usually insufficiently
studied and most studies focused on depression11; the
previous study12 reported a prevalence of 11% among type
2 diabetic patients compared to 6.1% of the general
population.Excessive daytime sleepiness is often attributed to seden-
tary lifestyle or laziness whereas it may be a manifestation of
serious disorders such as depression, diabetes, and obstruc-
tive sleep apnoea. The relationship between these diseases is
complex and multi-directional because each disorder may
exacerbate the other. Repetitive hypoxia and sleep frag-
mentation lead to the release of tumour necrosis factor and
fatigue related cytokines that affect diabetes control. Addi-
tionally, daytime sleepiness leads to an impaired mood state
that may impede diabetes management.13 The relationship
between the glycated haemoglobin and diabetes mellitus
prognosis has been established in large prospective
cohorts.14 Good glycaemic control is essential for the
maintenance and reduction of retinopathy, nephropathy,
neuropathy, and cardiovascular diseases, the glycated
haemoglobin (HbA1c) is the primary target for glycaemic
control. The American Diabetes Association recommends
an HbA1 of 7%. Diabetic patients with psychiatric
disorders have poorer treatment outcomes than those
without.15,16 Therefore, active case finding and
management of depression, anxiety, and daytime sleepiness
in diabetic patients can contribute to diabetes control
alleviating patient suffering and reducing the costs of
patient management.17 Thus, we conducted this research to
study depression, anxiety, and daytime sleepiness among
patients with type 2 diabetes mellitus and their relationship
with diabetes control in Tabuk, KSA.Materials and Methods
This case-control study conducted at the Diabetes Center
at King Khalid Hospital in Tabuk during the period from
March to June 2015. A systematic random sampling tech-
nique was used to select one hundred and seventy-eight pa-
tients with the diagnosis of type 2 diabetes according to the
American Diabetes Association guidelines: (HbA1c%  6.5,
or fasting plasma sugar 125 mg/dl, or 2 h after oral glucose
tolerance test 200 mg/dl. Patients with classic symptoms of
hyperglycaemia or hyperglycaemic crisis random plasma
sugar  200 mg/dl)18 who attended the diabetes centre for
follow-up, and one hundred control subjects (matched for
age). A ratio of 1:1 was used for subjects. The controls
subjects were randomly selected from the co-patients
(spouses, neighbours, and friends) attending the diabetes
centre. The control subjects were selected in this way to
address confounding factors such as educational and socio-
economic differences.19 Co-patients known to have diabetes
mellitus were not included. All subjects were asked to sign a
written informed consent form and interviewed using a
standard questionnaire based on the Arabic versions of Beck
Depression Inventory (BDI), Hamilton Anxiety Scale, and
The Epworth Sleepiness Scale (ESS). Patients with rheumatic
disorders or other chronic diseases and those on antide-
pressant medications for neuropathic pain were not included
in the study. The BDI has been previously validated20 for the
diagnosis of depression and has a high sensitivity and
specificity for detecting severe depression. There is also
evidence of utility and sensitivity of this measure for use in
patients with diabetes mellitus.3 The BDI consists of 21
items including emotional, behavioural, and somatic
Table 1: Characteristics of 178 patients with type 2
diabetes.
Character Mean  SD
Age 47.6  12.32
Sleeping hours/night 7.44  1.19
ESS 5.48  2.45
BMI 28.93  5.75
Duration of diabetes 6.72  5.86
HbA1c 12.5  6.2
Depression score 11.69  6.1
Anxiety score 7.41  3.78
Table 2: Characteristics of 100 control subjects.
Character Mean  SD
Age 45.94  9
Sleeping hours/night 7.78  1.15
ESS 2.56  1.24
Depression score 7.76.9  5.6
Anxiety score 5.39  3.32
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0 ¼ “no” and 3 ¼ “the greatest dysfunction”. Mild,
moderate, and severe depression has a rating of (10e18),
(19e29) and (30), respectively. The Arabic version of the
Epworth Sleepiness Scale (ESS): a well-validated self-re-
ported scale21 for testing daytime sleepiness asks “how likely
are you to doze or fall asleep?” in 8 typical situations:
Watching TV, sitting and reading, sitting inactive in public
places, as a passenger in a car for one hour without a
break, lying down to rest in the afternoon when
circumstances permit, sitting talking to someone, sitting
quietly after a lunch without alcohol, and in a car, while
stopped for a few minutes in traffic. Each component score
from 0 to 3 with 0 ¼ “no tendency to doze” and
3 ¼ “severe tendency to doze.” A total score of 10 out of
24 is regarded as having “daytime sleepiness”. The
Hamilton Anxiety Scale measures feelings of anxiety with
fourteen components (1e6 and 14 items measuring the
more subjective affective and cognitive symptoms of
anxiety) and is useful for assessing the severity of anxiety
disorder, and somatic anxiety (7e13 items for features of
general anxiety disorder such as cardiovascular,
gastrointestinal, and autonomic arousal).22 Each
component rating from 0 to 4 with four indicating the
greatest dysfunction, a score of fourteen or more is
regarded as anxiety. The collected information included
demographic data, duration of diabetes if diagnosed with
depression or antidepressant medications, height, weight,
and body mass index (BMI) as calculated by the formula:
body mass index ¼ weight/(height in metres).2 A blood
sample was taken for glycated haemoglobin estimation for
the degree of control using a HbA1C glycol haemoglobin
reagent set from Siemens Healthcare Diagnostics Newark,
DE 19714, USA. A glycated hemoglobin of  eight was
considered to be acceptable glycaemic control.23
The Statistical Package for Social Sciences (SPSS Inc.,
Chicago, IL. version 20) was used for data analysis. The chi-
square test was used to compare categorical data. Data were
reported as the mean  sd or percentages unless otherwise
specified, with a P-value of <0.05 being considered
significant.Table 3: Comparison between diabetic patients and control






Depression 110 (61.8%) 30 (30%) 0.000
Anxiety 6 (3.3%) 5 (5%) 0.504
Daytime sleepiness 12 (6.7%) 0 (0%) 0.008Results
Out of 278 subjects 178 were diabetics, their ages ranged
from 28 to 75 years with a mean of 47.6  12.32, the average
duration of hours of sleep per night was 7.44  1.19 h; the
Epworth Sleepiness Score was 5.48  2.45, and duration of
diabetes was 6.72  5.86 years. Table 1 illustrated other
patient characteristics.
Table 2 depicted the characteristics of the control
subjects. The mean age was 45.94  nine years, the mean
night-time hours of sleep was 7.78  1.15; Epworth Sleepi-
ness Score was 2.56  1.24; the average depression score was
7.76.9  5.6, and the average anxiety score was 5.39  3.32.
In the present study, depression was evident in 61.8% of
diabetic subjects vs. 30% of controls with a highly significant
difference (P-value < 0.001), excessive daytime sleepiness
was reported in 6.7% of diabetic patients, while no control
subjects fulfil the daytime sleepiness score for excessive
daytime sleepiness. Anxiety was found in 3.3% of patientswith diabetes and 5% of controls with no significant differ-
ence (P-value ¼ 0.504), Table 3.
In the current data, mild depression was found in 35.9%
of diabetic patients vs. 25% of control subjects, moderate
depression in 24.8% vs. 5% of controls, while severe
depression was evident in 1.1% of diabetic patients vs. 1% of
control subjects, Table 4.
On comparing diabetic patients with acceptable diabetes
control against those with poor diabetes control, depression
was evident in 71.7% of patients with acceptable diabetes
control and 76.6% of those with poor control with no sig-
nificant difference (P-value ¼ 0.293), anxiety was found in
4.3% for both groups (P-value ¼ 0.980), while excessive
daytime sleepiness was observed among 9.8% and 6.3% of
acceptable vs. poor diabetes control, respectively (P-
value ¼ 0.50). Table 5.
In the present study, depression was present in 14.6% of
the normal weight subjects, 23% of the overweight subjects,
21% of obese subjects, and in 2.8% of morbidly obese pa-
tients with no significant difference (P-value ¼ 0.48). Table 6
illustrated the relationship of depression, EDS, and HbA1 to
the body mass index.
In the current data, 100% of patients with excessive
daytime sleepiness were depressed vs. 59% of those without
EDS with significant differences (P-value ¼ 0.011) Figures 1
and 2.
Table 4: The severity of depression among patients with type 2
diabetic patients and control subjects.





Table 5: relationship of HbA1c to various parameters.





Depression 66 (71.7%) 36 (76.6%) 0.293
Anxiety 4 (4.3%) 2 (4.3%) 0.980
Daytime sleepiness 9 (9.8%) 3 (6.3%) 0.500
Table 6: The relationship of depression, EDS, and HbA1c to






Depression 14.6% 23% 21.3% 2.8% 0.481
EDS 1.1% 3.3% 2.2% 0% 0.764
HbA1c  8 8.4% 22.5% 0% 1.6% 0.191











Figure 2: Depression among Diabetic Patients without EDS.
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In the present study, depression was found in 61.8% of
diabetic patients and 30% of control subjects (who had not
been previously diagnosed). Consistent with our findings, a
study conducted in Gasim KSA7 reported depression in
nearly half of the patients with type 2 diabetes. Similarly,
Palizqir et al. in Iran24 reported depression in (70%) of
diabetic patients. The current prevalence in this study was
higher than previously reported studies conducted in KSA
and Zabol which reported depression in 31.1% and 34%,
respectively.25,26 A researcher from Riyadh KSA5 in his
research on diabetic patients (type 1, type 2, and










Figure 1: Depression among Diabetic Patients with EDS.(37.9% in type 2 diabetes). One plausible explanation is the
relatively small size of his study (39 type 2 diabetic
patients). In the current study, mild, moderate, and severe
depression were evident in 35.9%, 24.8%, and 1.1%,
respectively, consistent with the present finding from
Mirghani et al.27 who reported that mild and moderate
depression were more common than severe depression
among Sudanese diabetic patients.
In the current study, no statistically significant difference
was reported between depressed and non-depressed diabetic
patients with regards to glycated haemoglobin. Similar
studies from Germany11 indicated that no relationship
between affective disorders and glycated haemoglobin after
controlling for socio-demographic data, mental health utili-
zation, and personality characteristics. In contrast to the
present data Almahalli7 conducted a study in Eastern KSA
and found that depressed patients with type 2 diabetes had
poor glycaemic control. In addition, previous studies28
reported poor diabetes control among patients with
moderately severe/severe depression. This can be explained
by the fact that only a minority (1.1%) of the current
sample had severe depression. Similarly, researchers from
Japan reported a significant relationship between severity
of depression and diabetes complications among elderly
patients.29
The present data showed that excessive daytime sleepiness
was evident in 6.7% of diabetic patient and was not detected
in control subjects with significant difference. This is
consistent with the present finding by Ramtahal et al.30
which reported that 11.3% of diabetic patients had
excessive daytime sleepiness, a study in KSA31 reported a
prevalence of excessive daytime sleepiness in 20.5% of
subjects and is higher than our reported data. This can be
explained by the difference in the number of hours of sleep
and the small study sample size. In the present study, we
found no statistically significant difference between patients
with and without excessive daytime sleepiness with regards
to diabetes control. Similarly researchers from Korea32
reported that excessive daytime sleepiness was present in
8.5% of diabetic patients but not related to the degree of
diabetes control.
In the present study anxiety was reported in 3.3% of
diabetic patients and 5% of control subjects with no statis-
tically significant difference, in contrast Kruse et al.11
reported a significant difference between patients with
diabetes and controls with regards to anxiety. This may be
explained by the different methods used (i.e., the Hamilton
Depression, anxiety, and daytime sleepiness and diabetes control378Anxiety Scale versus the Composite International Diagnostic
interview used in the Kruse study). In addition age,
occupation, and income may be different between the two
samples.
Previous studies33 have linked excessive daytime
sleepiness, overweight, and obesity to incident depression.
In the current study, depression was more common among
patients with excessive daytime sleepiness. In agreement
with the previously mentioned observation, no significant
differences were evident between normal weight,
overweight, and obese patients regarding, EDS, depression,
and glycated haemoglobin. This may be explained by the
smaller sample size of the current study, or differences in
age, gender, and menopausal status between the groups.34
In the present study less than a quarter of diabetic patients
(33/139 ¼ 23.7%) met the American Diabetes Association
(ADA) guidelines for the glycated haemoglobin (HbA1c)
targets (HbA1c 12.5  6.2). Similar studies from KSA35
reported that only 24.2% of diabetic patients met the goals
for HbA1c. Researchers from Riyadh KSA36 reported a
rate of 18e35% achievement of HbA1c targets which is in
agreement with the current data.
In conclusion: Depression and excessive daytime sleepi-
ness were more common among patients with type 2 diabetes
in Tabuk, KSA. We found no difference in anxiety rate be-
tween diabetic patients and control subjects. No significant
differences were observed in patients with depression, day-
time sleepiness, and anxiety with regards to HbA1c and body
mass index. Low rate of achievement of the HaA1c targets
was reported.
The current study has many limitations: First the small
size of the survey sample, secondly it was conducted at a
single diabetic centre. In addition we were unable to control
for confounding factors such as diabetic complications
because the glycated haemoglobin was not measured for
control subjects to exclude undiagnosed diabetes mellitus or
prediabetic cases.
Recommendations: Screening for depression and exces-
sive daytime sleepiness should be part of holistic diabetes
care for early detection and treatment when appropriate.
Larger multicentre studies are needed to investigate pre-
dictors of high glycated haemoglobin (HbA1c). Measures
to improve the diabetes control in Tabuk, KSA are
strongly recommended. Physicians looking for patients
with diabetes need to follow the guidelines for the man-
agement of diabetes.Conflict of interest
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